Shroud Splits Scientists

SANTA FE, N.M.—No project in modern times has brought science and religion into closer contact than efforts to assess the authenticity of the Shroud of Turin. And the debate about the role of scientists in the project has been every bit as heated as the religious discussions. At the center of the controversy is a group of scientists that make up the Shroud of Turin Research Project (STURP). Formed here in 1976, the 30 or so volunteers rely on private donations to conduct their work. Robe

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

At the center of the controversy is a group of scientists that make up the Shroud of Turin Research Project (STURP). Formed here in 1976, the 30 or so volunteers rely on private donations to conduct their work.

Robert Dinegar, a retired physical chemist at Los Alamos National Laboratory, is one of the organizers of STURP. He is also an ordained Episcopal priest. Although Dinegar says that STURP members come from a diverse religious background that includes Catholics, Protestants, Jews and agnostics, outsiders say that the group's religious bias is strong enough to warrant its exclusion from the upcoming trials.

Last fall Vatican officials agreed in principle to a battery of tests, including carbon-14 dating, on the relic that is held by many believers to be the burial cloth of Jesus. Scientists close to the work expect tests to begin as early as this month.

According to the protocol pro ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Louis Weisberg

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide